Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Acronyms DEAR
- 07 Jun 2017 Biomarkers information updated
- 01 Apr 2011 Planned End Date changed from 1 Dec 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 07 Oct 2009 New trial record.